Delivery Order SPE2DB22D2009-SPE2DB26FL5WS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,773.00 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count) on August 25, 2025, with completion scheduled for August 26, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count units) under a firm fixed-price contract valued at $2,426.70. The award was made on October 17, 2025, with an ultimate completion date of October 20, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,808.62. This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a child delivery order executed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) with a ceiling value of $5,951.28 under a firm fixed price contract. This non-competitive delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Telmisartan 80 mg tablets (30-count) with a contract value of $1,530.22. This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,006.30 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. Performance of this delivery order will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract is a child order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,431.31 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count) on October 17, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order, awarded without set-aside designation through competitive procurement, represents a routine pharmaceutical supply transaction supporting federal medical needs. The award was issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,942.04 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed-price contract valued at $1,125.72. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, and was executed without a set-aside designation, indicating open competition. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB26FL5WSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) valued at $6,703.75 under a firm fixed-price contract. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-competitive delivery order executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its established position as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order operates under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract facilitates product delivery to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, demonstrating AmerisourceBergen Drug Corp's substantial role in supporting federal medical supply chains across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 10/17/25 |